| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |